NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
Recruiting · NCT06737250 · Registry updated 2024-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 2 | 2024-12-17 | NCT06737250 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NOBO Medicine | 2 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |
| Catholic univ of Yeouido St Mary's Hospital | Seoul | South Korea | 2 |
| Chonnam National University Hwasun Hospital | Hwasun | South Korea | 12 |
| Korea National Cancer Center | Ilsan | South Korea | 1 |
| Korea University ANAM Hospital | Seoul | South Korea | 56 |
| Kosin University Gospel Hospital | Busan | South Korea | 9 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Bundang Hospital | Seongnam | South Korea | 42 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Ulsan University Hospital | Ulsan | South Korea | 37 |